BlackRock Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$81K Sell
20,434
-84
-0.4% -$615 ﹤0.01% 3115
2016
Q3
$215K Buy
20,518
+1,537
+8% +$22.1K ﹤0.01% 2645
2016
Q2
$277K Sell
18,981
-63,150
-77% -$1.08M ﹤0.01% 2449
2016
Q1
$1.58M Sell
82,131
-11,817
-13% -$239K ﹤0.01% 1539
2015
Q4
$2.27M Buy
93,948
+53,366
+132% +$1.34M ﹤0.01% 1361
2015
Q3
$996K Buy
40,582
+20,532
+102% +$581K ﹤0.01% 1694
2015
Q2
$470K Buy
20,050
+1,146
+6% +$25K ﹤0.01% 2222
2015
Q1
$424K Buy
18,904
+3,465
+22% +$66.4K ﹤0.01% 2195
2014
Q4
$260K Sell
15,439
-741
-5% -$11.3K ﹤0.01% 2458
2014
Q3
$231K Sell
16,180
-65,436
-80% -$943K ﹤0.01% 2519
2014
Q2
$1.31M Sell
81,616
-69,108
-46% -$1.04M ﹤0.01% 1339
2014
Q1
$2.72M Buy
150,724
+104,092
+223% +$1.93M ﹤0.01% 1101
2013
Q4
$914K Buy
46,632
+35,068
+303% +$513K ﹤0.01% 1569
2013
Q3
$138K Buy
11,564
+99
+0.9% +$1.25K ﹤0.01% 2758
2013
Q2
$126K Buy
+11,465
New +$242K ﹤0.01% 2749

Other funds holding DVAX

BlackRock Advisors's DVAX Position: Q4 2016 in Review

BlackRock Advisors reduced its Dynavax Technologies (DVAX) stake by 0.41% in Q4 2016, selling an estimated $615 and leaving 20,434 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

BlackRock Advisors first reported a position in DVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.72M in Q1 2014. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

  • BlackRock Advisors held 20,434 shares of Dynavax Technologies worth $81K as of Q4 2016.
  • BlackRock Advisors sold 84 Dynavax Technologies shares in Q4 2016, an estimated $615.
  • Dynavax Technologies made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3115 holding.
  • BlackRock Advisors first reported a position in Dynavax Technologies in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Dynavax Technologies position peaked at $2.72M in Q1 2014.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.